期刊
BIOTECHNOLOGY JOURNAL
卷 16, 期 2, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.202000005
关键词
cancer therapeutics; metal-organic framework composites; nanomedicine; targeted drug delivery; theragnostic metal-organic frameworks
资金
- European Research Council (ERC) [ERC-2016-COG 726380]
- EPSRC grant NanoDTC [EP/L015978/1]
- Royal Society
Metal-organic frameworks (MOFs) are promising materials for cancer drug delivery due to their high drug uptake capacities and slow-release mechanisms. MOF-composite materials with added functionality, such as externally triggered drug release and improved pharmacokinetics, show potential for applications in nanomedicine. Further research is needed to develop biomedical expertise and advanced targeting techniques in this field.
Among a plethora of nano-sized therapeutics, metal-organic frameworks (MOFs) have been some of the most investigated novel materials for, predominantly, cancer drug delivery applications. Due to their large drug uptake capacities and slow-release mechanisms, MOFs are desirable drug delivery vehicles that protect and transport sensitive drug molecules to target sites. The inclusion of other guest materials into MOFs to make MOF-composite materials has added further functionality, from externally triggered drug release to improved pharmacokinetics and diagnostic aids. MOF-composites are synthetically versatile and can include examples such as magnetic nanoparticles in MOFs for MRI image contrast and polymer coatings that improve the blood-circulation time. From synthesis to applications, this review will consider the main developments in MOF-composite chemistry for biomedical applications and demonstrate the potential of these novel agents in nanomedicine. It is concluded that, although vast synthetic progress has been made in the field, it requires now to develop more biomedical expertise with a focus on rational model selection, a major comparative toxicity study, and advanced targeting techniques.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据